Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 19, 2020
Oncological outcomes in the management of cT1-T2 cN0 penile squamous cell carcinomaJuan Garisto, Madhur Nayan, Kamel Fadaak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of successJoelle Helou, Laura D'Alimonte, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate BrachytherapyAlexandru Nicolae, Gerard Morton, Hans Chung, et al.
Frontiers in Oncology|November 7, 2014
Measurement of mean cardiac dose for various breast irradiation techniques and corresponding risk of major cardiovascular eventTomas Rodrigo Merino Lara, Emmanuelle Fleury, Shahram Mashouf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trialYasir Alayed, Patrick Cheung, William Chu, et al.
Brachytherapy|May 22, 2019
Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of lifeNoelia Sanmamed, Peter Chung, Alejandro Berlin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 28, 2024
Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysisVivian S Tan, Jerusha Padayachee, George B Rodrigues, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
Brachytherapy|November 22, 2022
Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trialNoelia Sanmamed, Jenna Adleman, Alejandro Berlin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2020
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 GyGerard Morton, Merrylee McGuffin, Hans T Chung, et al.
Pageof 7